Abstract

Further points could influence outcome. The use of antibiotics is not mentioned, although its effect and its influence on the immune defense system, especially in appendicitis, is well known. 7 Similarly, the use of nonsteroidal anti-inflammatory drugs has not been reported. 8 Surgical experience may further influence outcome, especially in single-center studies, a factor that is not easily corrected for in surgical research.
The authors' conclusion is virtually exclusively based on the evolution of blood or serum surrogates of systemic inflammation. In the experimental surgical literature, more sophisticated general or local immune balance readouts can be used. They include skin tests to assess the temporary suppression of delayed-type hypersensitivity as a parameter of recall immunity, 3 biologic behavior of peritoneal macrophages, including their cytokine production, or number and survival of polymorphonuclear granulocytes as a marker for local immune response.4–6 In the context of a randomized, clinical study, similar assessments are clearly difficult to obtain.
Despite the evident nonblinded study design, it is very difficult to neglect the highly significant difference in hospital-stay length of nearly 2 days. At a first glance, it is an imprecise parameter of disease, including recovery. In the context of a “standard disease,” it primarily reflects recovery and, thus, quality of treatment. Although the study was nonblinded, this integral patients' evolution parameter strongly underlines that such a huge difference is of both high clinical and biologic relevance. It, therefore, suggests a less favorable recovery after open operated appendicitis, if compared to laparoscopically operated patients.
Actually, both expert opinion as well as literature tend to a minimally invasive approach for appendicitis.9,10 The interpretation of the article of Simon et al. 1 as a study that suggests equal biologic consequences of laparotomy versus laparoscopy seems very doubtful to us. Only excellent study designs can, in the longer course, bridge the gap between experimental and clinical surgery and, in the longer course, translate into improved clinical care.
